United-Guardian, Inc.

UG

US9105711082

Pharmaceuticals

Delayed Nasdaq Other stock markets 10:56:27 2024-04-29 am EDT			5-day change	1st Jan Change
8.28 ^USD	+0.12%		+1.85%	+15.00%

Mar. 22	United-Guardian, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 22	United-Guardian, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

United-Guardian, Inc. Declares Year-End Dividend, Payable on December 7, 2022

November 21, 2022 at 09:00 am EST

United-Guardian, Inc. declared a cash dividend of $0.31 per share, which will be paid on December 7, 2022 to all stockholders of record on November 28, 2022.

Latest news about United-Guardian, Inc.

United-Guardian, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 22	CI
United-Guardian, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 22	CI
Global markets live: Meta, Amazon, Apple, Tesla, Intel...	Feb. 02
United-Guardian Increases Dividend to $0.25 a Share, Payable Feb. 20 to Stockholders of Record Feb. 12; Shares up 5.1%	Feb. 02	MT
United-Guardian, Inc. Declares Cash Dividend, Payable on February 20, 2024	Feb. 02	CI
United-Guardian Appoints Catherine Joy Kolinski as Director	Jan. 08	CI
Earnings Flash (UG) UNITED-GUARDIAN Posts Q3 Revenue $3.1M	Nov. 06	MT
Earnings Flash (UG) UNITED-GUARDIAN Reports Q3 EPS $0.14	Nov. 06	MT
United-Guardian, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 06	CI
Earnings Flash (UG) UNITED-GUARDIAN Reports Q2 Revenue $2.7M	23-08-11	MT
United-Guardian, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
United-Guardian Declares Mid-Year Dividend, Payable on June 1, 2022	23-07-14	CI
United-Guardian, Inc. Declares Cash Dividend, Payable on August 2, 2023	23-07-14	CI
United-Guardian, Inc. Announces Resignation of Beatriz Blanco as Chief Executive Officer	23-06-13	CI
United-Guardian, Inc. Announces Beatriz Blanco Would Be Ending Her Employment as President of the Company	23-06-13	CI
United-Guardian, Inc. Appoints Donna Vigilante as President	23-06-13	CI
Transcript : United-Guardian, Inc. - Shareholder/Analyst Call	23-05-17
Earnings Flash (UG) UNITED-GUARDIAN Posts Q1 EPS $0.16	23-05-11	MT
Earnings Flash (UG) UNITED-GUARDIAN Posts Q1 Revenue $2.6M	23-05-11	MT
United-Guardian, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
United-Guardian, Inc. Declares Year-End Dividend, Payable on December 7, 2022	22-11-21	CI
United-Guardian, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-09	CI
Earnings Flash (UG) UNITED-GUARDIAN Posts Q3 Revenue $2.4M	22-11-09	MT
Earnings Flash (UG) UNITED-GUARDIAN Reports Q3 EPS $0.07	22-11-09	MT
United-Guardian Names Beatriz Blanco President, CEO	22-10-25	MT

United-Guardian, Inc. is engaged in manufacturing and marketing cosmetic ingredients, pharmaceutical products, medical lubricants and sexual wellness ingredients. Cosmetic ingredients include a line of multifunctional hydrogel formulations designed to offer sensory enhancement, lubrication, texture and moisturization to personal care products. Its cosmetic ingredients include Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural and Lubrajel Terra. Medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. Pharmaceutical products include an FDA approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial. Sexual wellness ingredients include a line of hydrogel formulations designed to offer sensory enhancement, lubrication and moisturization to sexual wellness applications.

Sector

Pharmaceuticals

Calendar

2024-05-08 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
UNITED-GUARDIAN, INC.	+15.00%	38M
ELI LILLY AND COMPANY	+25.84%	661B
NOVO NORDISK A/S	+26.74%	566B
JOHNSON & JOHNSON	-6.67%	352B
MERCK & CO., INC.	+20.41%	332B
ABBVIE INC.	+2.72%	283B
ASTRAZENECA PLC	+13.51%	231B
NOVARTIS AG	+4.69%	200B
ROCHE HOLDING AG	-9.41%	195B
AMGEN INC.	-5.22%	145B